Human synovial cells
IL-1 MODIFIES SYSTEM A TRANSPORT ACTIVITY IN HUMAN RHEUMATOID SYNOVIAL CELLS
✍ Scribed by VALÉRIE LE MAIRE; ALAIN HERNVANN; HERVÉ LE MARECHAL; OHVANESSE G EKINDJIAN; CHRISTIAN AUSSEL
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 168 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1065-6995
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Given the importance of interleukin‐1 in both rheumatic diseases and the modulation of cell metabolic activities, we studied the action of this cytokine on the neutral amino acid transport A system on rheumatoid synovial cells. In these cells IL‐1 (1ng/ml) induced amino transport stimulation from 5min to 5h. This effect was obtained only after a starvation period. No concentration‐related effect was found for IL‐1‐stimulated MeAIB uptake, and the IL‐1‐mediated MeAIB uptake stimulation is independent of protein synthesis. Neosynthesis or post‐translational maturation of protein transport is a prerequisite for obtaining this effect. In conclusion, rheumatoid synovial cells exhibit a higher sensitivity for IL‐1 than osteoarthritic ones, probably related to their intense metabolic activity.
📜 SIMILAR VOLUMES
We studied the long-terms effects of interleukin-1beta (IL-1beta; 3 to 6 h) on alpha-(methylamino) isobutyric acid (MeAIB), a nonmetabolizable amino acid transported by system A. We found that IL-1beta induced a large decrease in MeAIB uptake by human osteoarthritic synovial cells and a concomitant
The transport of amino acids by normal rat hepatocytes and several hepatoma cell lines has been examined for inactivation by various protein-modifying reagents, including the sulfhydryl-preferring reagents N-ethylmaleimide (NEM) and p-chloromercuribenzene sulfonate (PCMBS). Uptake of 2-aminoisobutyr
## Platelet -activating factor (PAF) elicits a rapid and transient activation of the proto-oncogenes c-fos and cjun in SH-SYSY neuroblastoma cells, but only to a minor extent in Molt-4 T-lymphocytes. This effect is inhibited by pretreatment of cells with the PAF antagonist BN 52021, suggesting the